Introduction
comparison with full rescreening of only 10% of the negative workload [14] . non-NFR slides in five quintiles, has been shown to correlate with the probability that a significant epithelial abnormality will be found [15] . [16] . BD FocalPoint TM can be described as a system of RPS, defined as an initial, rapid microscopic inspection of a slide before a full routine evaluation [17] . The [18] , and were prepared as described elsewhere [19] .
It could be hypothesized that limiting the rescreening to highrisk human papillomavirus (HR HPV) positive slides (HR HPV
-
Previously reported clinical trials have shown superior performance for the detection of all abnormal cases when compared with manual screening
The cytological results were classified according to the Bethesda system 2001 [20] 
Isolation of DNA from cervical cells
DNA isolation from liquid-based cytology was performed as previously described [21] [22] [23] [22, 23] .
The Table 1 . Table 3 ). [23, 24] . In this study, 16 type-specific real-time PCRs were used to detect oncogenic HPV [22, 23] . Using the same real-time PCRs, Moberg and coworkers showed that the risk of developing cervical CIS or CIN 3 increases with higher viral load for most of the HPV types studied [25] and that HPV load is a type-dependent risk marker for invasive carcinoma [26] . Several studies have proven the prognostic value of HPV viral load in the evolution to cervical intraepithelial neoplasia [27] [28] [29] .
CIN 2+ cases and follow-up period

For all samples included in the QC series, a 36-month follow-up period was used. Our computer system was searched to identify cases with biopsyproven CIN 2+. As golden standard a CIN2+ histological outcome was considered as a positive follow-up result. Cytological follow-up was only included when minimum two consecutive negative smears were available, which was considered as absence of CIN 2+. For 1215 out of 1717 samples follow-up was available (70.8%). An overview of the number of followup cytology, of cytology with HPV status and of biopsies taken in each of the QC series is given in
Statistical analysis
Comparisons of means were studied by analysis of variance (ANOVA
Full rescreening of NFR, GS and MS
Yield of additional abnormal slides picked up by high-risk (HR) HPV-targeted rescreening
Comparison of the relative sensitivity of FRE versus HR HPV-targeted rescreening
Efficiency of full rescreening versus HR HPV-targeted reviewing and detection of HR HPV
Finally, general full rescreening of 1717 slides allowed detection of only four histological confirmed CIN 2+ cases (0.23%), whereas HR HPV-targeted rescreening of only 234 HR HPV positive slides yielded detection of eight CIN2+ cases (3.42%). This means that HR HPV-targeted rescreening is 15 times
Rank versus viral load
HPV typing and viral load cut-off for the visual detection of abnormal cytology/detection of CIN2+
HPV typing revealed 31 slides positive for oncogenic HPV types in the NFR group (6.1%), 50 in the MS group (10.0%) and 153 in the GS group (21.5%) ( 2 ϭ 73.1, P < 0.001). There was no difference in viral load between the different HR HPV types (P > 0.05). Therefore all HR HPV positives were pooled in the following analysis. Because all HPV HR positive slides (n ϭ 234) were rescreened with knowledge of HPV type but without knowledge of viral load (blinded), we could calculate the viral load cut-off for the visual detection abnormal cytology (ASC-US+). The viral load of oncogenic positive slides, which were labelled ASC-US or higher (150.2 copies/cell), was significantly higher than the oncogenic positive slides, which were deemed negative after rescreening
Moreover 
